Clinical Trial Update: Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum [NA]

View source ↗

Summary

A clinical trial is evaluating the effects of three months of melatonin treatment on regional cerebellar structure and blood biomarkers in the Alzheimer's disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Saint Vincent's Hospital, Korea | Conditions: Elderly, Alzheimer Disease | NA | Status: NOT_YET_RECRUITING